ILIUM XYLAZIL-20 ANALGESIC, SEDATIVE AND MUSCLE RELAXANT INJECTION

Страна: Австралия

Език: английски

Източник: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Активна съставка:

XYLAZINE AS THE HYDROCHLORIDE

Предлага се от:

TROY LABORATORIES PTY LTD

INN (Международно Name):

xylazine as HCl(20mg/mL)

Лекарствена форма:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Композиция:

XYLAZINE AS THE HYDROCHLORIDE THIAZOLE Active 20.0 mg/ml

Броя в опаковка:

20mL; 50mL

Клас:

VM - Veterinary Medicine

Произведено от:

TROY LABORATORIES

Терапевтична група:

CAT | CATTLE | DOG | GOAT | SHEEP | BEEF | BILLY | BITCH | BOS INDICUS | BOS TAURUS | BOVINE | BUCK | BUFFALO | BULL | BULLOCK |

Терапевтична област:

CENTRAL NERVOUS SYSTEM

Терапевтични показания:

ANALGESIC | MUSCLE RELAXANT | ANAESTHETIC | ANTIPYRETIC | COLIC | GENERAL ANAESTHETIC | MUSCLE RELAXANT | MUSCULAR SPASMS | PARASYMPATHOLYTIC AGENT | SEDATIVE | SPASMOLYTIC | STRYCHNINE POISONING

Каталог на резюме:

Poison schedule: 4; Withholding period: WHP: Meat: Do not use less than 28 days before slaughter for human consumption. Milk: Nil. ESI: This product does n ot have an ESI established.; Host/pest details: CAT: [ANALGESIC, MUSCLE RELAXANT]; CATTLE: [ANALGESIC, MUSCLE RELAXANT]; DOG: [ANALGESIC, MUSCLE RELAXANT]; GOAT: [ANALGESIC, MUSCLE RELAXANT]; SHEEP: [ANALGESIC, MUSCLE RELAXANT]; Poison schedule: 4; Withholding period: WHP: Meat: Do not use less than 28 days before slaughter for human consumption . Milk: Nil. ESI: This product does no t have an ESI established.; Host/pest details: CAT: [ANALGESIC, MUSCLE RELAXANT]; CATTLE: [ANALGESIC, MUSCLE RELAXANT]; DOG: [ANALGESIC, MUSCLE RELAXANT]; GOAT: [ANALGESIC, MUSCLE RELAXANT]; SHEEP: [ANALGESIC, MUSCLE RELAXANT]; Poison schedule: 4; Withholding period: ; Host/pest details: CAT: [ANALGESIC, MUSCLE RELAXANT]; CATTLE: [ANALGESIC, MUSCLE RELAXANT]; DOG: [ANALGESIC, MUSCLE RELAXANT]; GOAT: [ANALGESIC, MUSCLE RELAXANT]; SHEEP: [ANALGESIC, MUSCLE RELAXANT]; An analgesic, sedative and muscle relaxant injection for use in dogs, cats, sheep, goats and cattle.This product should not be administered to animals in the last month of pregnancy as it may precipitate an early parturition or abortion

Статус Оторизация:

Registered

Дата Оторизация:

2022-07-01

Листовка

25
July
2010
Main panel-Draft:
Ancillary panel-Draft
ILIUM
XYLAZ
IL-20
IMME
DIA
TE
LABEL
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
ILIUM XYLAZIL-20
ANALGESIC, SEDATIVE AND MUSCLE
RELAXANT INJECTION
ACTIVE CONSTITUE
NT
:
20 mg/mL XYLAZ
IN
E AS HYDROCHLO
RI
DE
ILI
UM
20mL/50
mL
Ilium Xylazil-20 is an analgesic, sedative and muscle relaxant
injection for use
in
dogs, cats, sheep, goats and cattle.
DIRECTIONS FOR USE:
READ THE ENCLOSED LEAFLET FOR DOSAGE AND FULL DIRECTIONS.
WITHHOLDING PERIODS:
MEAT: DO NOT USE LESS THAN 28 DAYS BEFORE SLAUGHTER FOR HUMAN
CONSUMPTION
MILK:
0 DAYS
TRADE ADVICE: EXPORT SLAUGHTER INTERVAL (ESI): This product
does not have
an
ES
I established. For advice on the ESI contact the
manufacturer on [phone] before using th is product.
FIRST AID: If poisoning occurs contact a doctor or Poisons Information
Centre. Phone Australia 131126.
TROY LABORATORIES PTY. LIMIT
ED
98 LONG S
T.
SMITHFIEL
D,
N
SW
2164 AUSTRA
LI
A
Dispose
of
empty container by wrappi
ng
with pap
er
and putting in the garbage.
Store below 30°C (Room Temperature).
APVMA Approval N
o.
386~MtlfrT1{)
6
~
bS3
/
S
o~
I
b
AWM:A:1XpproVa1
~
~315BMf:iB-746
Batch:
Expiry:
Version: V02
Page 1
of
1 RLP APPROVED
Info
PEST


Verified
25 July 2010
ILIUM XYLAZIL-20
LEAFLET
PRESCRIPTION ANIMAL REMEDY
KEEP OUT
OF
REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
ILIUM XYLAZIL-20 ANALGESIC, SEDATIVE AND MUSCLE
RELAXANT INJECTION
ACTIVE CONSTITUENT:
20
mg/ml
XYLAZINE AS HYDROCHLORIDE
20mL/50mL
DESCRIPTION:
XYLAZIL-20
is an injection containing 20
mg/ml
(2% w/v)
of
Xylaz
in
e (2-(2,6-xylidino)-5,6-
dihydro-4H-1 ,3-thiazine hydrochloride).
ACTION:
XYLAZIL-20
produces dose dependent sedation and analgesia through
an
alphamimetic and
direct opioid effect.
It also produces muscle relaxation by inhibition
of
the intraneuronal
transmission
of
impulses centrally
in
the CNS.
Direct stimulation
of
the emetic centre results
in
emesis
in
most cats and occasionally
in
the dog.
Onset
of
action after intravenous injecti

Данни за продукта

MATERIAL SAFETY DATA SHEET
PRODUCT NAME: ILIUM XYLAZIL-20 ANALGESIC, SEDATIVE AND MUSCLE RELAXANT
INJECTION
PAGE: 1 OF 4
THIS REVISION ISSUED: JULY, 2010
MATERIAL SAFETY DATA SHEET
Issued by: Troy Laboratories Australia Pty Ltd
Phone: [phone]
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND)
SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER
TROY LABORATORIES AUSTRALIA PTY. LTD ABN: 21 000 283 769
TEL:
[phone]
31-35 GLENDENNING ROAD
FAX:
[phone]
GLENDENNING NSW 2761
CHEMICAL NATURE:
Water solution of ingredients. Active ingredient is Xylazine is an
alpha-2 adrenergic,
non narcotic sedative.
TRADE NAME:
ILIUM XYLAZIL-20 ANALGESIC, SEDATIVE AND MUSCLE RELAXANT INJECTION
PRODUCT CODE:
3824
PRODUCT USE:
A non-narcotic analgesic, sedative and muscle relaxant for use in
dogs, cats, sheep,
goats and cattle. To be used as directed on product label.
CREATION DATE:
AUGUST, 2005
THIS VERSION ISSUED:
JULY, 2010
and is valid for 5 years from this date.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of SWA
Australia.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S25. Avoid contact with eyes.
SUSDP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
EMERGENCY OVERVIEW
PHYSICAL DESCRIPTION & COLOUR
: Clear, colourless liquid.
ODOUR:
Very faint odour.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product.
POTENTIAL HEALTH EFFECTS
This is a pharmacologically active preparation, and contact should be
avoided except in actual use. If you have come
into contact with this product, seek medical attention if you feel
drowsy or experience any unusual symptoms.
INHALATION
SHORT TERM EXPOSURE:
Significant inhalation exposure is considered to be unlikely.
Available data indicates th